Data di Pubblicazione:
2014
Abstract:
Bromocriptine and cabergoline, ergot derived dopamine receptor agonists used to treat Parkinson's disease and prolactinomas, have been associated with increased risk of cardiac valve disease. Here we present a case of iatrogenic symptomatic severe mitral regurgitation due to these drugs.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Cabergoline; Severe mitral regurgitation; Valve disease;
Elenco autori:
D'Aloia, A; Piovanelli, B; Rovetta, R; Bonadei, Ivano; Vizzardi, Enrico; Curnis, Antonio; Metra, Marco
Link alla scheda completa:
Pubblicato in: